account_id none on file
legal_name Imunon, Inc.
ticker IMNN
cik 749647
domain imunon.com
linkedin_company_url https://www.linkedin.com/company/imunon/
entry_point_account_id none on file
name Imunon Inc.
exchange Nasdaq
sector Health Care
hq Lawrenceville, NJ, United States
sector index/company/sector/health-care/
calls 1 filings 0 executives 5 family 0
why_nownone on file
calls
DNA expenses were $1.6 million in Q3 2025, down from $1.7 million in the same period last year, due to lower employee-related legal and travel expenses.
Nov 13, 2025 / receipt, needs a key / Kim Graper, interim chief financial officer | earnings call 2025-11-13 | transcript 53c2c028-bfc8-48e5-9672-c238e50601e5 | chars 18689-18841 | segment 19
filingsnone on file
executives
| Douglas Faller | Chief Medical Officer | - | receipt |
| Dr. Lindberg | CEO | - | receipt |
| Gregory Weaver | Senior Vice President and Chief Financial Officer | - | receipt |
| Kim Graper | interim chief financial officer | - | receipt |
| Stacey Lindborg | President and Chief Executive Officer | - | receipt |
familynone on file
upcoming
| 2026-11-12 | earnings call | scheduled | ir |
changes
| 2025-02-10 | Chief Medical Officer, appointed | sec_8k |
| 2011-07-12 | Senior Vice President and Chief Financial Officer, appointed | sec_8k |
| 2011-07-12 | Vice President and Chief Financial Officer, departed | sec_8k |
mcp_package_hint
slug imunon-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$